Ruxience 100 MG/10 ML vial 10ML
Ended Awarded
- Contract number
- SPE2DB23FU1MX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $394
Award facts
- Contract value 100% obligated
- $393.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $393.81 delivery order by the Defense Logistics Agency to provide 100 mg/10 ml vials of Ruxience, a biosimilar drug, for use by the Department of Defense. The firm fixed price order is for a single day of performance in Conshohocken, Pennsylvania and will support the DLA's pharmaceutical procurement programs. No subcontractors or set aside designations were identified.
Quick answers
Who was awarded contract SPE2DB23FU1MX?
SPE2DB23FU1MX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 9, 2023.
How much is contract SPE2DB23FU1MX worth?
The government has obligated $394 on SPE2DB23FU1MX.
Is contract SPE2DB23FU1MX an order under another contract?
Yes. SPE2DB23FU1MX is a delivery order under SPE2DB22D6029, an indefinite delivery contract.
Was contract SPE2DB23FU1MX competed?
The extent of competition for SPE2DB23FU1MX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award